Tag: 上海夜网RN

Top Stories

first_img Top Stories Arizona Cardinals safety Rashad Johnson left Sunday’s loss to the New Orleans Saints a little less than whole.The fifth-year pro was going down the field as part of the team’s punt coverage unit when, somehow, he severed the tip of his left middle finger. He didn’t return to the game.“It was pretty devastating for myself because it was a very close ballgame,” Johnson said Monday. “It was 7-7 at that point and it was a big game that I wanted to be a part of and wanted to do everything I could to help my teammates win. “I was thinking more about them and being more upset about that then I was, pretty much, about my finger.”Johnson commended the team’s trainers and coaching staff for handling the situation, and said the reality of him losing part of his finger did not set in until Monday morning.“I was joking around in the hospital, because they had some pretty good stuff to help me get through the pain,” he said, adding he was taking pictures and laughing about it. “It really didn’t set in until this morning when I got here and we took the gauze off and we got it cleaned up here and I actually got to see that it was the same length as my index finger.”The 2009 third-round pick out of Alabama said things like this happen, adding that you can’t play football without risking your health.That said, it’s not often a player loses part of a finger, so the recovery timetable is a bit uncertain.“The big part of it is infection just because the bone was exposed once I pulled it out of the glove, so they wanted to make sure that they got everything clean and got the stitches put in well,” he said, adding that pain tolerance is also part of the equation. Grace expects Greinke trade to have emotional impact Derrick Hall satisfied with D-backs’ buying and selling The 5: Takeaways from the Coyotes’ introduction of Alex Meruelo Former Cardinals kicker Phil Dawson retires Johnson is not too concerned about how the finger — or lack there of — will impact his play, saying the middle finger has little impact on how a player catches the ball. In fact, he said his middle finger “probably wasn’t getting used for anything good anyway.”But football or not, this is something he’s going to have to live with.“It’s a different injury. We hear about ACLs, we hear about shoulder separations or different things like that,” he said. “But for someone to actually lose a part of their finger, and that’s something that you can’t just go and put back on. It’s gone.“It’s something that I will be without, something that I will have to adjust to. At the end of the day, I’ve got nine more and just move forward with it.”The Arizona Cardinals Broadcast Department contributed to this report 0 Comments   Share   last_img read more

Japanese court rules against journalist in HPV vaccine defamation case

first_img Takuma Suda Email “I must win this case for the sake of  freedom of scientific speech and sound science.”  By Dennis NormileMar. 27, 2019 , 4:00 PM Japanese court rules against journalist in HPV vaccine defamation case A Japanese court ruled yesterday that a medical journalist who has championed vaccination to reduce the risk of cervical cancer defamed a neurologist by writing that he had fabricated data showing a link between the vaccine and brain damage in mice.The case had been closely watched by vaccine proponents, who worried the decision might embolden those in Japan and elsewhere who claim shots against the human papillomavirus (HPV) cause chronic pain and movement disorders in humans. To their relief, the court in Tokyo didn’t address that question; it only said that Riko Muranaka, a doctor, medical writer, and lecturer at Kyoto University in Japan, had not provided evidence that neurologist Shuichi Ikeda had made up the data behind his controversial claim.The case comes against a backdrop of deep mistrust against the HPV vaccine, introduced in Japan in 2009 and added to the national vaccine program in April 2013. That same year, some vaccine recipients complained about severe side effects. In June 2013, the health ministry suspended its recommendation that all girls in their early teens receive the vaccine, causing the vaccination rate to drop from 70% for girls born in the mid-1990s to 1% today. The health ministry has also funded research and set up advisory panels to study the alleged side effects. Country * Afghanistan Aland Islands Albania Algeria Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia, Plurinational State of Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, the Democratic Republic of the Cook Islands Costa Rica Cote d’Ivoire Croatia Cuba Curaçao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See (Vatican City State) Honduras Hungary Iceland India Indonesia Iran, Islamic Republic of Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Korea, Democratic People’s Republic of Korea, Republic of Kuwait Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macedonia, the former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Martinique Mauritania Mauritius Mayotte Mexico Moldova, Republic of Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Norway Oman Pakistan Palestine Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Qatar Reunion Romania Russian Federation Rwanda Saint Barthélemy Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Martin (French part) Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten (Dutch part) Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania, United Republic of Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Venezuela, Bolivarian Republic of Vietnam Virgin Islands, British Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe Riko Muranaka did not provide evidence that research data were fabricated, a court in Tokyo said. Sign up for our daily newsletter Get more great content like this delivered right to you! Country In March 2016, Ikeda, a neurologist at Shinshu University in Matsumoto, Japan, showed one such panel data purportedly showing brain damage in a mouse given the HPV vaccine. He repeated the claim for a news crew later the same day.In the June 2016 issue of the business magazine Wedge, Muranaka claimed Ikeda had not performed the experiments himself; she also said only a single mouse had been given the vaccine, and that a slide purportedly showing brain damage in Ikeda’s presentation didn’t come from that mouse. “The inescapable conclusion is that there was an ‘intention of fabrication,’” wrote Muranaka, who in 2017 was awarded the John Maddox Prize for Standing up for Science.The magazine article triggered an investigation by Shinshu University, which concluded in November 2016 that Ikeda had presented preliminary results based on an experiment with one mouse as “scientifically proven.” Japan’s health ministry issued a statement saying Ikeda’s results “have not proven anything about whether the symptoms that occurred after HPV vaccination were caused by the HPV vaccine,” and blasting him for his “very regrettable” responsibility in “causing misunderstanding among citizens.”But the court sidestepped questions about the vaccine itself and ruled that Muranaka had not provided convincing evidence of fabrication. Muranaka and the magazine will have to pay Ikeda 3.3 million yen (about $29,900), plus part of his legal expenses. They also must post an apology and delete portions of the online article.Ikeda welcomed the ruling, saying a charge of fabrication would leave him “unable to address academic society,” according to press reports of a postruling press conference. He seemed to downplay the significance of what he said previously about the mouse experiments, arguing they were just one way to clarify why some vaccine recipients suffer brain disorders.“I am sorry to hear [the] Tokyo district court ignored science and [the] public interest,” Muranaka wrote in a statement posted online. However, “This decision has nothing to do with the safety of the HPV vaccines,” she noted. Women who saw Ikeda’s presentation on TV and decided against vaccination “lost the chance to protect their life and health,” Muranaka wrote. She told Science that she will appeal. “I must win this case for the sake of  freedom of scientific speech and sound science,” she says.  The battle over HPV vaccines in Japan is set to continue. Vaccinees have brought class action lawsuits against two vaccine producers and the health ministry seeking damages for alleged side effects. Those suits are expected to drag on for years.Meanwhile, evidence for the safety and efficacy of the three HPV vaccines on the worldwide market continues to grow. In a July 2017 update, for instance, the World Health Organization’s Global Advisory Committee on Vaccine Safety noted that at the time 270 million doses of HPV vaccines had been distributed. There is “no evidence to suggest a causal association” between the HPV vaccine and the various syndromes or symptoms reported as side effects, the update states, adding that the committee “considers HPV vaccines to be extremely safe.” As for efficacy, the update noted that countries that have included HPV vaccines in national immunization programs have seen a 50% decrease in the incidence of cervical precancerous lesions among younger women.Whether the verdict will have any impact outside Japan remains to be seen. “I think what is important is that media coverage does not distort the point and imply Dr. Ikeda’s science won: It was Dr. Muranaka’s manners and language that lost,” says Heidi Larson, director of the Vaccine Confidence Project at the London School of Hygiene & Tropical Medicine.*Correction, 28 March, 5:05 a.m.: The headline of this story has been adjusted to show the court did not find the defendant guilty, though it did rule in favor of the plaintiff in a civil defamation suit. Click to view the privacy policy. Required fields are indicated by an asterisk (*) Riko Muranaka last_img read more